Shell Asset Management Co. cut its stake in Illumina, Inc. (NASDAQ:ILMN) by 6.2% during the second quarter, Holdings Channel reports. The fund owned 24,711 shares of the life sciences company’s stock after selling 1,635 shares during the period. Shell Asset Management Co.’s holdings in Illumina were worth $4,288,000 as of its most recent SEC filing.
Other large investors have also added to or reduced their stakes in the company. RMB Capital Management LLC acquired a new stake in Illumina during the fourth quarter valued at about $219,000. Kentucky Retirement Systems acquired a new stake in Illumina during the fourth quarter valued at about $1,365,000. Kentucky Retirement Systems Insurance Trust Fund acquired a new stake in Illumina during the fourth quarter valued at about $609,000. Private Asset Management Inc. raised its stake in Illumina by 10.5% in the first quarter. Private Asset Management Inc. now owns 8,142 shares of the life sciences company’s stock valued at $1,389,000 after buying an additional 775 shares during the last quarter. Finally, Chevy Chase Trust Holdings Inc. raised its stake in Illumina by 33.0% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 346,451 shares of the life sciences company’s stock valued at $59,114,000 after buying an additional 85,922 shares during the last quarter. 93.68% of the stock is owned by institutional investors.
Illumina, Inc. (NASDAQ ILMN) opened at 174.92 on Monday. The company has a market capitalization of $25.54 billion, a P/E ratio of 35.40 and a beta of 0.84. The stock has a 50 day moving average of $174.65 and a 200-day moving average of $171.62. Illumina, Inc. has a 52-week low of $119.37 and a 52-week high of $189.48.
TRADEMARK VIOLATION NOTICE: This story was originally posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this story on another domain, it was illegally copied and reposted in violation of U.S. and international trademark & copyright law. The correct version of this story can be read at https://stocknewstimes.com/2017/07/31/shell-asset-management-co-sells-1635-shares-of-illumina-inc-nasdaqilmn.html.
ILMN has been the subject of several recent research reports. Zacks Investment Research raised shares of Illumina from a “hold” rating to a “buy” rating and set a $191.00 price objective for the company in a research report on Tuesday, April 4th. Vetr raised shares of Illumina from a “buy” rating to a “strong-buy” rating and set a $190.90 price objective for the company in a research report on Tuesday, April 4th. Leerink Swann reissued a “buy” rating on shares of Illumina in a research report on Wednesday, April 5th. TheStreet raised shares of Illumina from a “c+” rating to a “b” rating in a research report on Thursday, April 6th. Finally, Bank of America Corporation increased their price objective on shares of Illumina from $175.00 to $195.00 and gave the stock a “buy” rating in a research report on Tuesday, April 11th. Four equities research analysts have rated the stock with a sell rating, eight have given a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the stock. Illumina currently has an average rating of “Hold” and a consensus price target of $167.02.
In other news, SVP Charles Dadswell sold 1,609 shares of the business’s stock in a transaction on Wednesday, May 3rd. The shares were sold at an average price of $187.07, for a total value of $300,995.63. Following the sale, the senior vice president now owns 10,936 shares in the company, valued at approximately $2,045,797.52. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Omead Ostadan sold 1,672 shares of the business’s stock in a transaction on Friday, July 7th. The shares were sold at an average price of $172.73, for a total transaction of $288,804.56. Following the completion of the sale, the executive vice president now owns 26,242 shares in the company, valued at approximately $4,532,780.66. The disclosure for this sale can be found here. Insiders have sold 125,248 shares of company stock worth $22,281,673 in the last quarter. Corporate insiders own 1.60% of the company’s stock.
Illumina Company Profile
Illumina, Inc (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations.
Want to see what other hedge funds are holding ILMN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Illumina, Inc. (NASDAQ:ILMN).
Receive News & Ratings for Illumina Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Illumina Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
